Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Recent Study: Evotec AG - Product Pipeline Review - 2013


Print article Print article
2013-08-11 15:08:49 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's pharmaceuticals report, "Evotec AG - Product Pipeline Review - 2013" provides data on the Evotec AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Evotec AG's corporate website, SEC filings, investor presentations and featured press releases, both from Evotec AG and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Evotec AG - Brief Evotec AG overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Evotec AG human therapeutic division.
* Overview of pipeline therapeutics

across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Evotec AG with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Evotec AG's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/666707_evotec_ag_product_pipeline_review_201 ..

Reasons to Get this Report

* Evaluate Evotec AG's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Evotec AG in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Evotec AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Evotec AG.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Evotec AG and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Evotec AG Snapshot
Evotec AG Overview
Key Information
Key Facts
Evotec AG - Research and Development Overview
Key Therapeutic Areas
Evotec AG - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Evotec AG - Pipeline Products Glance
Evotec AG Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Evotec AG - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Evotec AG - Drug Profiles
Antiviral Program
Product Description
Mechanism of Action
R&D Progress
B1 Antagonists
Product Description
Mechanism of Action
R&D Progress
BACE
Product Description
Mechanism of Action
R&D Progress
Drug For Anemia
Product Description
Mechanism of Action
R&D Progress
Drug For Endometriosis
Product Description
Mechanism of Action
R&D Progress
Drug For Kidney Diseases
Product Description
Mechanism of Action
R&D Progress
Drug For Neuropathic Pain
Product Description
Mechanism of Action
R&D Progress
EVT-201
Product Description
Mechanism of Action
R&D Progress
EVT-401
Product Description
Mechanism of Action
R&D Progress
EVT-501
Product Description
Mechanism of Action
R&D Progress
Insulin Sensitizer
Product Description
Mechanism of Action
R&D Progress
Kv1.3 Inhibitors
Product Description
Mechanism of Action
R&D Progress
Oncology Program
Product Description
Mechanism of Action
R&D Progress
Orexin-1 Antagonist
Product Description
Mechanism of Action
R&D Progress
Orexin-2
Product Description
Mechanism of Action
R&D Progress
P2X3 and P2X2/3 Antagonist
Product Description
Mechanism of Action
R&D Progress
PDE10a Inhibitors
Product Description
Mechanism of Action
R&D Progress
Serine Racemase Inhibitors
Product Description
Mechanism of Action
R&D Progress
Evotec AG - Pipeline Analysis
Evotec AG - Pipeline Products by Therapeutic Class
Evotec AG - Pipeline Products By Target
Evotec AG - Pipeline Products by Route of Administration
Evotec AG - Pipeline Products By Mechanism of Action
Evotec AG - Recent Pipeline Updates
Evotec AG - Dormant Projects
Evotec AG - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
EVT-301
RG-1577
REN-1654
Evotec AG - Company Statement
Evotec AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Evotec AG, Key Information
Evotec AG, Key Facts
Evotec AG - Pipeline by Indication, 2013
Evotec AG - Pipeline by Stage of Development, 2013
Evotec AG - Monotherapy Products in Pipeline, 2013
Evotec AG - Phase II, 2013
Evotec AG - Phase I, 2013
Evotec AG - Preclinical, 2013

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=666707&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com